Clinical Trials on Platinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-line
Total 117 results
-
Bristol-Myers SquibbCompletedPlatinum-sensitive Ovarian Cancer, Second-line, Third-line, or Fourth-lineUnited States
-
Jules Bordet InstituteHoffmann-La RocheRecruitingMetastatic Colorectal Cancer | Unresectable Locally Advanced Colorectal Cancer | Candidate for Third-line or Subsequent Lines of TherapyBelgium, France
-
TJ Biopharma Co., Ltd.WithdrawnFirst-line Non-small-cell Lung Cancer | First-line Urothelial Carcinoma | Second-line Urothelial Carcinoma | Second-line MelanomaChina
-
TILT Biotherapeutics Ltd.Merck Sharp & Dohme LLCRecruitingPlatinum-resistant Ovarian Cancer | Platinum-Resistant Fallopian Tube Carcinoma | Platinum-Resistant Primary Peritoneal Carcinoma | Platinum-Refractory Fallopian Tube Carcinoma | Platinum-Refractory Primary Peritoneal Carcinoma | Platinum-refractory Ovarian Carcinoma | Platinum-Sensitive Ovarian... and other conditionsUnited States, Finland
-
Second Affiliated Hospital of Zunyi Medical UniversityGuizhou Provincial People's Hospital; The First People's Hospital of Zunyi; Guizhou... and other collaboratorsRecruitingImmunotherapy | Second-line TreatmentChina
-
Queen Mary Hospital, Hong KongRecruitingQuality of Life | Burns | Self Efficacy | Burn Injury | Adherence, Treatment | Burn Second Degree | Burns Third DegreeChina
-
Sponsor GmbHGlaxoSmithKline; iOMEDICO AG; Arbeitsgemeinschaft fur Internistische Onkologie; Arbeitskreis Klinische StudienTerminatedMetastatic Breast Cancer | HER2 Positive | First or Second Line Therapy | Failure or Contraindication of Trastuzumab TherapyGermany
-
The Affiliated Hospital of Qingdao UniversityRecruitingGastric or Gastro-oesophageal Junction Carcinoma | Advanced, Relapsed Gastric or Gastro-oesophageal Junction Carcinoma | Second-line TherapyChina
-
IRCCS Cancer Referral Center of BasilicataCompletedGastric Cancer | Ramucirumab | Third Line
-
Institut Claudius RegaudCompletedMetastatic Breast Cancer Starting a Third Line ChemotherapyFrance
-
Zhejiang Cancer HospitalNot yet recruitingSecond Line Treatment of Gastric Cancer
-
AstraZenecaMerck Sharp & Dohme LLC; European Network of Gynaecological Oncological Trial... and other collaboratorsActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum Sensitive | BRCA MutatedKorea, Republic of, France, China, Italy, United States, Israel, United Kingdom, Canada, Japan, Germany, Brazil, Netherlands, Belgium, Poland, Australia, Russian Federation, Spain
-
AstraZenecaActive, not recruitingRelapsed Ovarian Cancer | Following Complete or Partial Response to Platinum Based Chemotherapy | Platinum SensitiveChina, Malaysia
-
Institut Paoli-CalmettesCompleted
-
Assistance Publique Hopitaux De MarseilleUnknownElderly | Locally Advanced or Metastatic CancerFrance
-
The Hospital for Sick ChildrenPediatric Oncology Group of OntarioCompletedQuality of Life | Feasibility | Psychological Distress | Pediatric Cancer | Cancer, Treatment-Related | YogaCanada
-
Novartis PharmaceuticalsCompletedEndometrial Cancer | VEGF | Solid Tumors and Advanced Endometrial Cancer | Second-line TreatmentItaly, United Kingdom, Spain, Brazil, United States, Korea, Republic of, New Zealand
-
Jiangsu HengRui Medicine Co., Ltd.CompletedSecond-line Treatment for Locally Advanced or Metastatic Pancreatic Cancer After Treatment Failure With Gemcitabine-based TherapyChina
-
University Hospital, EssenGerman Cancer AidNot yet recruitingAdvanced Lung Carcinoma | NSCLC Stage IV | NSCLC Stage IIIB | First Line Treatment | Second Line Treatment | Palliative Treatment | NSCLC Stage IIICGermany
-
Peking Union Medical College HospitalNot yet recruitingEfficacy and Safety of Surufatinib Combined With Envafolimab as Second or More-line Therapy in Advanced Soft Tissue Sarcoma Patients
-
Genzyme, a Sanofi CompanyCompletedNon-Small Cell Lung Cancer (NSCLC, Locally Advanced or Metastatic, Second-lineUnited States, Czech Republic, Hungary
-
AstraZenecaMerck Sharp & Dohme LLC; GOG Foundation; Myriad Genetic Laboratories, Inc.Active, not recruitingAdvanced Ovarian Cancer | Newly Diagnosed | FIGO Stage III-IV | Partial Response | Complete Response | BRCA Mutation | First Line Platinum ChemotherapyKorea, Republic of, France, Italy, United States, Israel, Canada, China, Brazil, United Kingdom, Poland, Australia, Japan, Netherlands, Russian Federation, Spain
-
National Health Research Institutes, TaiwanChina Medical University Hospital; Chang Gung Memorial Hospital; Kaohsiung Medical... and other collaboratorsNot yet recruitingChemotherapy | Metastatic Gastric Adenocarcinoma | Second Line
-
Selcuk UniversityEnrolling by invitationCancer | Neuropathy | Therapy-Associated CancerTurkey
-
EMD Serono Research & Development Institute, Inc.Merck KGaA, Darmstadt, GermanyCompletedUnresectable, Recurrent, Locally Advanced or Metastatic Gastric or Gastroesophageal Junction Adenocarcinoma | Gastric Cancer Third LineSpain, Italy, Australia, Korea, Republic of, Belgium, France, Poland, United States, Czechia, Germany
-
Tianjin Medical University Cancer Institute and...UnknownNon-small Cell Lung Cancer | Second-line TreatmentChina
-
Federal University of the Valleys of Jequitinhonha...CompletedClinical Trial | Third Molar | OzoneBrazil
-
Xidian UniversityAir Force Military Medical University, ChinaCompletedQuality of Life | Breast Cancer | Cancer-related Fatigue | Cancer, Therapy-RelatedChina
-
Novartis PharmaceuticalsCompletedFirst or Second Line HER2-negative Breast Cancer | Metastatic Disease Without Bone MetastasisUnited States
-
AGO Study GroupTerminatedAnemia | Epithelial Ovarian Cancer, Fallopian Tube or Peritoneum | Platinum Sensitve RelapseGermany
-
Vrije Universiteit BrusselUniversity of British Columbia; University of Coimbra; Amsterdam UMC, location... and other collaboratorsNot yet recruitingCancer (Active Cancer, Meaning Not Being Cancer Free), of Any Stage and Involving Any Treatment/Care Regimen; i.e. Curative, Life-extending, or Palliative
-
OSI PharmaceuticalsCompletedLocally Recurrent or Metastatic Cancer of the Head and Neck | Must Have Failed First-Line TherapyUnited States
-
Medical University of ViennaCompletedQuality of Life | Ovarian Cancer | ChemotherapyAustria
-
Zhongda HospitalRecruitingSafety and Efficacy of TCR-like CAR-TChina
-
AGO Study GroupEssex Pharma GmbH; MedServ. GmbH, WiesbadenCompletedCervical Cancers | Cancer of the Ovary Treated as 2nd Line Therapy | Muellerian Mixed Tumours | Tumours of the Uterus | Non-Epithelial Ovarian TumoursGermany
-
North Eastern German Society of Gynaecological...PharmaMar; Frankfurter Institut für Klinische Krebsforschung IKF GmbHCompletedQuality of Life | Ovarian Cancer | Recurrent Ovarian CarcinomaGermany
-
Shanghai JMT-Bio Inc.Not yet recruitingFirst-line Treatment of HER2-positive Recurrent or Metastatic Breast Cancer
-
Centre Francois BaclesseTerminatedHead and Neck Cancer | Radiotherapy by Tomotherapy Exclusive | With or Without Concurrent ChemotherapyFrance
-
National Center for Complementary and Integrative...CompletedOvarian CancerUnited States
-
Per PfeifferCompletedFirst-line Treatment for Patients With Non-resectable Gastric Cancer or Cancer of the Esophagus orDenmark
-
Northwestern UniversityNational Cancer Institute (NCI)CompletedQuality of Life | Ovarian CancerUnited States
-
Hospital Carlos Van BurenUniversidad de Valparaiso; University of Chile; Universidad de La Frontera; Hospital... and other collaboratorsCompletedHealth-related Quality of Life | Dentofacial DeformitiesChile
-
Oslo University HospitalEuropean Organisation for Research and Treatment of Cancer - EORTCCompletedQuality of Life | Cancer | Xerostomia | Adverse Effects | Late EffectsNorway, Netherlands, Sweden, Germany, United Kingdom, Greece, France, Israel, Italy, Poland
-
Ankara UniversityCompleted
-
Northwestern UniversityTerminated
-
Fundació Institut de Recerca de l'Hospital de la...RecruitingHereditary Breast and Ovarian CancerSpain
-
Centre Hospitalier Universitaire de NīmesRecruiting
-
Memorial Sloan Kettering Cancer CenterQueens Cancer Center of Queens HospitalCompletedQuality of Life | Epithelial Ovarian Cancer | SurvivorshipUnited States
-
University of BirminghamCompletedOvarian NeoplasmsUnited Kingdom
-
IRCCS San RaffaeleActive, not recruitingQuality of Life | Breast Cancer | Radiotherapy; Adverse Effect, Dermatitis or EczemaItaly